Net Worth Advisory Group’s AbbVie ABBV Stock Holding History

Net Worth Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.29M	Buy	4,982 +203	+4%	+$52K	0.33%	58
2026 Q2	$1.2M	Sell	4,779 -2,222	-32%	-$478K	0.3%	63
2026 Q1	$1.52M	Buy	7,001 +932	+15%	+$207K	0.32%	68
2025 Q4	$1.39M	Buy	6,069 +2,244	+59%	+$511K	0.28%	67
2025 Q3	$886K	Sell	3,825 -2,285	-37%	-$465K	0.26%	74
2025 Q2	$1.13M	Buy	6,110 +2,434	+66%	+$452K	0.25%	79
2025 Q1	$770K	Buy	3,676 +91	+3%	+$17.7K	0.24%	87
2024 Q4	$637K	Buy	3,585 +24	+0.7%	+$4.41K	0.19%	123
2024 Q3	$703K	Buy	+3,561	New	+$665K	0.21%	117

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Net Worth Advisory Group's ABBV Position: Q3 2026 in Review

Net Worth Advisory Group increased its AbbVie (ABBV) stake by 4.2% in Q3 2026, buying an estimated $52K and bringing the position to 4,982 shares worth $1.29M. The position accounts for 0.33% of the portfolio, ranked #58.

Net Worth Advisory Group first reported a position in ABBV in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.52M in Q1 2026. 1,209 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Net Worth Advisory Group held 4,982 shares of AbbVie worth $1.29M as of Q3 2026.
Net Worth Advisory Group bought 203 AbbVie shares in Q3 2026, an estimated $52K.
AbbVie made up 0.33% of Net Worth Advisory Group's portfolio in Q3 2026, its #58 holding.
Net Worth Advisory Group first reported a position in AbbVie in Q3 2024 and has held it in 9 quarters since.
Net Worth Advisory Group's AbbVie position peaked at $1.52M in Q1 2026.
1,209 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Net Worth Advisory Group's 13F filing for Q3 2026, filed 20 Oct 2026.